Vigil Neuroscience Email Format
Biotechnology ResearchUnited States51-200 Employees
Vigil Neuroscience, a Sanofi company, is a clinical-stage biotechnology company focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. We are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities in our efforts to develop precision-based therapies to improve the lives of patients and their families.